COMP <GO>
BRAI vs IBEX // EV/EBITDA & P/E VALUATION
Braiin Limited (NASDAQ) VS. IBEX Limited (NASDAQ) • 15-METRIC TALLY: BRAI 1
— IBEX 1
■ METRIC PARITY
LAST: $3.06 (-15.00%) • MKT CAP: $630.6M
valuation
—
LAST: $45.35 (-0.66%) • MKT CAP: $605.2M
valuation
9.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BRAI VS. IBEX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BRAI | IBEX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 26.50% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 9.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 4.51% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | 8.30% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 0.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 9.80% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.51 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 7/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 31.7 | 51.5 | -19.88 | IBEX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $630.6M | $605.2M | $25.5M | BRAI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BRAI REV | IBEX REV | BRAI GROSS % | IBEX GROSS % | BRAI FCF | IBEX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $558.3M | — | — | — | $27.3M |
| FY 2024 | — | $508.6M | — | — | — | $27.0M |
| FY 2023 | — | $523.1M | — | — | — | $41.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BRAI // BETA —
IBEX // BETA —